cannabidiol Epidiolex
Selected indexed studies
- Epilepsy and cannabidiol: a guide to treatment. (Epileptic Disord, 2020) [PMID:32096470]
- Cannabidiol: pharmacology and therapeutic targets. (Psychopharmacology (Berl), 2021) [PMID:33221931]
- Cannabidiol Adverse Effects and Toxicity. (Curr Neuropharmacol, 2019) [PMID:31161980]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Epilepsy and cannabidiol: a guide to treatment. (2020) pubmed
- Cannabidiol: pharmacology and therapeutic targets. (2021) pubmed
- Cannabidiol Adverse Effects and Toxicity. (2019) pubmed
- Cannabidiol (Epidiolex) for epilepsy. (2018) pubmed
- Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. (2021) pubmed
- Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. (2024) pubmed
- [Cannabidiol]. (2020) pubmed
- Cannabidiol and epilepsy. (2024) pubmed
- Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. (2023) pubmed
- Endometriosis: cannabidiol therapy for symptom relief. (2024) pubmed